CareMax (CareMax) Research & Development : $0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is CareMax Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. CareMax's Research & Development for the three months ended in Dec. 2023 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.0 Mil.

CareMax Research & Development Historical Data

The historical data trend for CareMax's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareMax Research & Development Chart

CareMax Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Research & Development

CareMax Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial										-	-	-	-	-

CareMax Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

CareMax (NAS:CMAX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CareMax Research & Development Related Terms

Thank you for viewing the detailed overview of CareMax's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

CareMax (CareMax) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareMax Inc (NAS:CMAX) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

1000 NW 57th Court, Suite 400, Miami, FL, USA, 33126

Website

https://www.caremax.com

CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

Executives

Bryan Cho	director	30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
De La Torre Ralph	director, 10 percent owner	4939 BROOKVIEW DRIVE, DALLAS TX 75220
Ryan Oquinn	director	1000 NW 57 COURT, SUITE 400, MIAMI FL 33126
Kevin Berg	director	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Beatriz Maria Assapimonwait	director	1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Vincent Omachonu	director	1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jose Ramon Rodriguez	director	PRIMORIS SERVICES CORPORATION, 2300 NORTH FIELD STREET, SUITE 1900, DALLAS TX 75201
Related Cm Advisor, Llc	director	30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
Imc Holdings, Lp	10 percent owner	525 OKEECHOBEE BOULEVARD, SUITE 1050, WEST PALM BEACH FL 33401
William C. Lamoreaux	officer: EVP	1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Kevin Wirges	officer: EVP, Treasurer and CFO	1000 NW 57 CT., SUITE 400, MIAMI FL 33126
De Solo Carlos A.	director, officer: President and CEO	1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Randy Simpson	director	C/O GLENVIEW CAPITAL MANAGEMENT, LLC, 767 FIFTH AVENUE, 44TH FLOOR, NEW YORK NY 10153
Solo Alberto De	officer: EVP and COO	1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jennifer L. Carter	director	C/O DFP SPONSOR LLC, 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017